The Board of Directors resolved on January 23, 2025, conditional on approval of an extra ordinary general meeting, to carry out a new share issue of up to approximately SEK 25.6 million with preferential rights for existing shareholders. The extraordinary general meeting on February 12, 2025, resolved to approve the Rights Issue. Complete information, terms, and instructions regarding the Rights Issue can be found in the Memorandum. The Memorandum is only available in Swedish and since February 19 available on Heliospectra’s website, www.heliospectra.com.
Indicatief tijdschema
Het volgende tijdschema voor de claimemissie is voorlopig en kan worden gewijzigd.
| Handel in aandelenrechten | 19 February 2025 – 28 February 2025 |
| Abonnementsperiode | 19 February 2025 – 5 March 2025 |
| Handel in volgestorte aandelen (BTA) | 19 February 2025 – week 12 2025 |
| Verwachte aankondiging van het resultaat van de claimemissie | 6 maart 2025 |
Adviseurs
MAQS Advokatbyrå AB is juridisch adviseur van de Vennootschap in verband met de claimemissie en Aqurat Fondkommission AB is issuing agent in de claimemissie.

